Annual SG&A
$18.16 M
+$869.00 K+5.02%
31 March 2022
Summary:
Sio Gene Therapies annual selling, general & administrative expenses is currently $18.16 million, with the most recent change of +$869.00 thousand (+5.02%) on 31 March 2022. During the last 3 years, it has risen by +$869.00 thousand (+5.02%).SIOX Selling, General & Administrative Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly SG&A
$2.60 M
-$341.00 K-11.59%
31 December 2022
Summary:
Sio Gene Therapies quarterly selling, general & administrative expenses is currently $2.60 million, with the most recent change of -$341.00 thousand (-11.59%) on 31 December 2022.SIOX Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM SG&A
-$3.49 B
-$28.83 M-0.83%
31 December 2022
Summary:
Sio Gene Therapies TTM selling, general & administrative expenses is currently -$3.49 billion, with the most recent change of -$28.83 million (-0.83%) on 31 December 2022.SIOX TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SIOX Selling, General & Administrative Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | - | - |
| 3 y3 years | +5.0% | -73.3% | -10000.0% |
| 5 y5 years | -54.0% | -48.5% | -10000.0% |
SIOX Selling, General & Administrative Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | ||||||
| 5 y | 5 years | ||||||
| alltime | all time | -74.7% | -91.4% | -4354.7% |
Sio Gene Therapies Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2022 | - | $2.60 M(-11.6%) | $9.00 M(-14.2%) |
| Sept 2022 | - | $2.94 M(-1.7%) | $10.49 M(-39.4%) |
| June 2022 | - | $2.99 M(+536.6%) | $17.30 M(-4.8%) |
| Mar 2022 | $18.16 M(+5.0%) | $470.00 K(-88.5%) | $18.16 M(-16.1%) |
| Dec 2021 | - | $4.09 M(-58.1%) | $21.66 M(-0.5%) |
| Sept 2021 | - | $9.75 M(+152.6%) | $21.77 M(+31.8%) |
| June 2021 | - | $3.86 M(-2.7%) | $16.51 M(-4.5%) |
| Mar 2021 | $17.29 M(-21.6%) | $3.96 M(-5.6%) | $17.29 M(-6.3%) |
| Dec 2020 | - | $4.20 M(-6.5%) | $18.46 M(-6.2%) |
| Sept 2020 | - | $4.49 M(-3.2%) | $19.67 M(-2.8%) |
| June 2020 | - | $4.64 M(-9.6%) | $20.23 M(-8.3%) |
| Mar 2020 | $22.06 M(-44.1%) | $5.13 M(-5.1%) | $22.06 M(-4.4%) |
| Dec 2019 | - | $5.41 M(+7.1%) | $23.09 M(-19.3%) |
| Sept 2019 | - | $5.05 M(-21.9%) | $28.61 M(-16.3%) |
| June 2019 | - | $6.47 M(+5.1%) | $34.18 M(-13.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2019 | $39.47 M(-45.1%) | $6.16 M(-43.7%) | $39.47 M(+11.0%) |
| Dec 2018 | - | $10.93 M(+2.9%) | $35.55 M(-16.6%) |
| Sept 2018 | - | $10.62 M(-9.6%) | $42.65 M(-31.4%) |
| June 2018 | - | $11.75 M(+423.8%) | $62.14 M(-13.6%) |
| Mar 2018 | $71.91 M(+57.3%) | $2.24 M(-87.6%) | $71.91 M(-12.3%) |
| Dec 2017 | - | $18.03 M(-40.1%) | $81.96 M(+8.9%) |
| Sept 2017 | - | $30.11 M(+39.9%) | $75.27 M(+37.8%) |
| June 2017 | - | $21.52 M(+75.0%) | $54.61 M(+19.4%) |
| Mar 2017 | $45.72 M(-19.1%) | $12.30 M(+8.4%) | $45.72 M(+12.7%) |
| Dec 2016 | - | $11.34 M(+20.0%) | $40.58 M(-29.4%) |
| Sept 2016 | - | $9.45 M(-25.2%) | $57.46 M(+6.9%) |
| June 2016 | - | $12.63 M(+76.6%) | $53.76 M(-4.9%) |
| Mar 2016 | $56.52 M | $7.15 M(-74.7%) | $56.52 M(+14.5%) |
| Dec 2015 | - | $28.23 M(+391.6%) | $49.37 M(+133.6%) |
| Sept 2015 | - | $5.74 M(-62.7%) | $21.14 M(+37.3%) |
| June 2015 | - | $15.39 M | $15.39 M |
FAQ
- What is Sio Gene Therapies annual selling, general & administrative expenses?
- What is the all time high annual SG&A for Sio Gene Therapies?
- What is Sio Gene Therapies quarterly selling, general & administrative expenses?
- What is the all time high quarterly SG&A for Sio Gene Therapies?
- What is Sio Gene Therapies TTM selling, general & administrative expenses?
- What is the all time high TTM SG&A for Sio Gene Therapies?
What is Sio Gene Therapies annual selling, general & administrative expenses?
The current annual SG&A of SIOX is $18.16 M
What is the all time high annual SG&A for Sio Gene Therapies?
Sio Gene Therapies all-time high annual selling, general & administrative expenses is $71.91 M
What is Sio Gene Therapies quarterly selling, general & administrative expenses?
The current quarterly SG&A of SIOX is $2.60 M
What is the all time high quarterly SG&A for Sio Gene Therapies?
Sio Gene Therapies all-time high quarterly selling, general & administrative expenses is $30.11 M
What is Sio Gene Therapies TTM selling, general & administrative expenses?
The current TTM SG&A of SIOX is -$3.49 B
What is the all time high TTM SG&A for Sio Gene Therapies?
Sio Gene Therapies all-time high TTM selling, general & administrative expenses is $81.96 M